Insider filing · ELVN
Lori Anne Kunkel
Director
profile →
Enliven Therapeutics, Inc.
ELVN · Healthcare · 56 filings in 24 months
ticker →
Lori Anne Kunkel sold $505K of Enliven Therapeutics (ELVN)
Executed Jul 6, disclosed Jul 8, 2 days later.
Value, as filed
$505K
10,000 sh across 2 lots
Executed
Jul 6
the trade date, as filed
Disclosed
Jul 8
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LKLori Anne Kunkel (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $505K of ELVN (10,000 sh across 2 lots, as filed), executed Jul 6.
The name
ELVNHealthcare · Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibito…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Lori Anne Kunkel in ELVN
ELVNSALE
Enliven Therapeutics, Inc.
$267K7,779 sh × $34.28
Exec Jun 5
Filed Jun 9 · 5:30 PM ET